Loading clinical trials…
Loading clinical trials…
Clinical trials
Studies registered on ClinicalTrials.gov whose conditions were reconciled to the cancer taxonomy. Status and phase are as posted by the registrant.
629 studies match
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05715047 | Intervention for Fatigue in HCT Recipients | completed | N/A | 66 | Massachusetts General HospitalOTHER | 1 | Jun 5, 2026 | clinicaltrials |
| NCT06934928 | Assessing the Efficacy of Repeat, Monthly Treatments of Alexandrite Laser for NF1-associated Cutaneous Neurofibromas (cNFs) | suspended | N/A | 10 | Massachusetts General HospitalOTHER | 1 | Jun 4, 2026 | clinicaltrials |
| NCT04430894 |
| KRDI in Transplant-Eligible MM |
| active not recruiting |
| Phase 2 |
| 50 |
| Massachusetts General HospitalOTHER |
| 1 |
| Jun 3, 2026 |
| clinicaltrials |
| NCT05418959 | Genetic Risk Stratification of Pediatric Skin Lesions | enrolling by invitation | Phase 1 | 100 | Massachusetts General HospitalOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT06115811 | Radiation Treatment Plan Evaluation Learning Tool Pilot Project | not yet recruiting | N/A | 20 | Massachusetts General HospitalOTHER | 1 | May 22, 2026 | clinicaltrials |
| NCT01885949 | Tivozanib + Enzalutamide in Adv Prostate Cancer | terminated | Phase 2 | 5 | Massachusetts General HospitalOTHER | 1 | May 20, 2026 | clinicaltrials |
| NCT04902833 | Acquired Pyruvate Kinase Deficiency In Clonal Myeloid Neoplasms | completed | — | 18 | Massachusetts General HospitalOTHER | 1 | May 19, 2026 | clinicaltrials |
| NCT05844033 | Biomarker for Infection Risk in CLL and MM | active not recruiting | — | 150 | Massachusetts General HospitalOTHER | 1 | May 19, 2026 | clinicaltrials |
| NCT03279237 | A Pilot Study of FOLFIRINOX in Combination With Neoadjuvant Radiation for Gastric and GE Junction Cancers | completed | Phase 1 | 25 | Massachusetts General HospitalOTHER | 1 | May 18, 2026 | clinicaltrials |
| NCT01673581 | Shared Decision Making in Low Risk Prostate Cancer | withdrawn | — | 0 | Massachusetts General HospitalOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT02792270 | Caloric Restriction In Sarcoma Patients Treated With Pre-Operative RT | recruiting | N/A | 32 | Massachusetts General HospitalOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT04776837 | Predicting Disease Progression and/or Recurrence in Cancer | completed | — | 159 | Massachusetts General HospitalOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT06862856 | Flotufolastat F 18 PET in Men With Very Low PSA Recurrence | recruiting | — | 50 | Massachusetts General HospitalOTHER | 1 | May 15, 2026 | clinicaltrials |
| NCT01696721 | Proton and Photon Consortium Registry (PPCR): A Multi Center Registry of Pediatric Patients Treated With Radiation Therapy | recruiting | — | 5,000 | Massachusetts General HospitalOTHER | 3 | May 14, 2026 | clinicaltrials |
| NCT06073353 | Psychosocial Mobile Application (THRIVE-M) for Patients With Multiple Myeloma(THRIVE-M) | active not recruiting | N/A | 120 | Massachusetts General HospitalOTHER | 1 | May 14, 2026 | clinicaltrials |
| NCT06786104 | Video Inspired Discussions About Ethical Outcomes in Pediatrics(VIDEO-PEDS) | recruiting | N/A | 567 | Massachusetts General HospitalOTHER | 1 | May 14, 2026 | clinicaltrials |
| NCT01115777 | Prospective Assessment of Quality of Life (QOL) in Pediatric Patients Treated With Radiation Therapy for Brain Tumors and Non-central Nervous System (Non-CNS) Malignancies | active not recruiting | — | 600 | Massachusetts General HospitalOTHER | 1 | May 13, 2026 | clinicaltrials |
| NCT07128355 | Botensilimab, Balstilimab, and SBRT in Colorectal Cancer | recruiting | Early Phase 1 | 15 | Massachusetts General HospitalOTHER | 1 | May 13, 2026 | clinicaltrials |
| NCT04801797 | Venetoclax + Azacitidine vs. Induction Chemotherapy in AML | active not recruiting | Phase 2 | 172 | Massachusetts General HospitalOTHER | 1 | May 12, 2026 | clinicaltrials |
| NCT05486520 | Low-field MRI for Breast Cancer Screening | enrolling by invitation | N/A | 40 | Massachusetts General HospitalOTHER | 1 | May 12, 2026 | clinicaltrials |
| NCT06910956 | Deep Learning Using Chest X-Rays to Identify High Risk Patients for Lung Cancer Screening CT | recruiting | N/A | 1,500 | Massachusetts General HospitalOTHER | 1 | May 11, 2026 | clinicaltrials |
| NCT03202940 | A Phase IB/II Study of Alectinib Combined With Cobimetinib in Advanced ALK-Rearranged (ALK+) NSCLC | active not recruiting | Phase 1 / Phase 2 | 16 | Massachusetts General HospitalOTHER | 1 | May 8, 2026 | clinicaltrials |
| NCT06181643 | Innovating CBT-I for Cancer Survivors: An Optimization Trial | active not recruiting | N/A | 80 | Massachusetts General HospitalOTHER | 1 | May 8, 2026 | clinicaltrials |
| NCT03990896 | Evaluation of Talazoparib, a PARP Inhibitor, in Patients With Somatic BRCA Mutant Metastatic Breast Cancer: Genotyping Based Clinical Trial | recruiting | Phase 2 | 30 | Massachusetts General HospitalOTHER | 1 | May 6, 2026 | clinicaltrials |
| NCT04430699 | Cisplatin+Pembrolizumab+RT in Vulvar Cancer | active not recruiting | Phase 2 | 24 | Massachusetts General HospitalOTHER | 1 | May 5, 2026 | clinicaltrials |
| NCT05692024 | COffee and Metabolites Modulating the Gut MicrobiomE in Colorectal caNCER(COMMENCER) | recruiting | Phase 1 / Phase 2 | 80 | Massachusetts General HospitalOTHER | 1 | May 5, 2026 | clinicaltrials |
| NCT06649851 | G-CSF After Chemo-radiation in Patients With Glioblastoma | recruiting | Phase 2 | 60 | Massachusetts General HospitalOTHER | 1 | May 5, 2026 | clinicaltrials |
| NCT03482102 | Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer | active not recruiting | Phase 2 | 37 | Massachusetts General HospitalOTHER | 1 | May 4, 2026 | clinicaltrials |
| NCT04752137 | Intraoperative Tumor Margin Identification With ICG Dye Imaging | recruiting | Phase 2 | 100 | Massachusetts General HospitalOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT06676852 | Feasibility and Acceptability of Primary Palliative Care Intervention in Patients Undergoing Hematopoietic Stem Cell Transplantation(Primary PC HCT) | recruiting | N/A | 40 | Massachusetts General HospitalOTHER | 1 | Apr 24, 2026 | clinicaltrials |
| NCT06300502 | Assessing the Efficacy of Repeat, Monthly Treatments of Deoxycholate for NF1 Associated Cutaneous Neurofibromas (cNFs) | enrolling by invitation | Phase 1 | 15 | Massachusetts General HospitalOTHER | 1 | Apr 22, 2026 | clinicaltrials |
| NCT04544046 | Supportive Oncology Care At Home RCT | active not recruiting | N/A | 300 | Massachusetts General HospitalOTHER | 1 | Apr 21, 2026 | clinicaltrials |
| NCT05646576 | Defining the Role of Palliative carE for Patients With Hematologic Malignancies Undergoing Adoptive CEllular Therapy(PEACE) | recruiting | N/A | 90 | Massachusetts General HospitalOTHER | 1 | Apr 21, 2026 | clinicaltrials |
| NCT06915662 | Pain Outcomes After Digital Amputation Using Tulavi Allay™ Nerve Cap | recruiting | Phase 2 | 20 | Massachusetts General HospitalOTHER | 1 | Apr 17, 2026 | clinicaltrials |
| NCT05013892 | NTS-WBRT in Brain Metastases | recruiting | Phase 2 | 41 | Massachusetts General HospitalOTHER | 1 | Apr 16, 2026 | clinicaltrials |
| NCT03768336 | A Stress Management and Resiliency Program for Adolescent and Young Adult Survivors | active not recruiting | N/A | 72 | Massachusetts General HospitalOTHER | 1 | Apr 14, 2026 | clinicaltrials |
| NCT05702723 | Building Resiliency Among Caregivers of Curvivors and Metavivors(ForTe) | completed | N/A | 94 | Massachusetts General HospitalOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT07032714 | Mezigdomide and Talquetamab in Relapsed and Refractory Multiple Myeloma(MAGENTA) | recruiting | Phase 1 | 25 | Massachusetts General HospitalOTHER | 1 | Apr 13, 2026 | clinicaltrials |
| NCT06067347 | A Global Study of the PETAL Consortium(PETAL) | recruiting | — | 1,200 | Massachusetts General HospitalOTHER | 4 | Apr 9, 2026 | clinicaltrials |
| NCT03310918 | A Collaborative Palliative and Leukemia Care Model for Patients With AML and MDS Receiving Non-Intensive Therapy | active not recruiting | N/A | 320 | Massachusetts General HospitalOTHER | 1 | Apr 6, 2026 | clinicaltrials |
| NCT03822312 | A Pilot Study of Tomographic Optical Breast Imaging (DBT-TOBI) to Monitor Response to Neoadjuvant Therapy | active not recruiting | N/A | 30 | Massachusetts General HospitalOTHER | 1 | Apr 6, 2026 | clinicaltrials |
| NCT05607017 | Losartan in Prevention of Radiation-Induced Heart Failure | completed | Early Phase 1 | 5 | Massachusetts General HospitalOTHER | 1 | Apr 6, 2026 | clinicaltrials |
| NCT04881916 | Immune and Genomic Markers in ALK+ NSCLC | active not recruiting | — | 100 | Massachusetts General HospitalOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT04980404 | Inqovi Maintenance Therapy in Myeloid Neoplasms | active not recruiting | Phase 1 | 22 | Massachusetts General HospitalOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT05087251 | The Transitions Project: Efficacy Trial | active not recruiting | N/A | 100 | Massachusetts General HospitalOTHER | 1 | Mar 30, 2026 | clinicaltrials |
| NCT03286530 | Ruxolitinib + Allogeneic Stem Cell Transplantation in AML | active not recruiting | Phase 2 | 64 | Massachusetts General HospitalOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT03752268 | Development of an Intervention to Enhance Cancer Pain Management | active not recruiting | N/A | 150 | Massachusetts General HospitalOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT04450043 | The Transitions Project: Supporting Adults During the Shift From Cancer Treatment to Surveillance | active not recruiting | N/A | 21 | Massachusetts General HospitalOTHER | 1 | Mar 27, 2026 | clinicaltrials |
| NCT03328663 | Psychological Intervention for Caregivers of Patients Undergoing Stem Cell Transplant | completed | N/A | 100 | Massachusetts General HospitalOTHER | 1 | Mar 20, 2026 | clinicaltrials |
| NCT06440135 | Ziftomenib Maintenance Post Allo-HCT | recruiting | Phase 1 | 22 | Massachusetts General HospitalOTHER | 1 | Mar 19, 2026 | clinicaltrials |
Data updated 23 days agoSource updated unknownsource: clinicaltrials